Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi-center study

Blood Cancer J. 2016 Feb 26;6(2):e400. doi: 10.1038/bcj.2016.8.

A Lu¹, Y Fang², X Du³, Y Li⁴, Z Cai⁵, K Yu⁶, L Zhao², B Wang¹, J Wu¹, Y Cheng¹, Y Zuo¹, Y Jia¹, F Tan⁷, L Ding⁷, J Lu⁸, L Zhang¹, X Huang⁸

¹ Department of Pediatrics, Peking University People's Hospital, Beijing, China.
² Department of Phase 1 Clinical Trial, Peking University People's Hospital, Beijing, China.
³ Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
⁴ The First Hospital of China Medical University, Shenyang, China.
⁵ The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
⁶ The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
⁷ Betta Pharmaceuticals Co., Ltd, Hangzhou, China.
⁸ Institute of Hematology, Peking University People's Hospital, Beijing, China.

No abstract available

Publication types